|
|
Controversies to Consensus in Diabetes, Obesity
and Hypertension (CODHy)
October 30 - November 2, 2008, Barcelona, Spain |
|
| |
| Industry Advisory Board (IAB) |
|
| We view industry not only as a sponsor of our academic activity but rather as partners that can promote new research and innovative developments that will undoubtedly originate from this challenging meeting of interdisciplinary experts of the highest quality. In addition, the IAB, including representatives of the congress sponsors, is expected to guide the organizing committee with innovations and new research that are in demand.
| L. Berman, Pfizer |
A. Gorska, Medtronic |
| K. Brown Frandsen, Novo Nordisk |
Z. Milicevic, Eli Lilly |
| R.L. Chaiken, Pfizer |
R. Niecestro, Accelapharm |
| M. Ganz, Roche diagnostics |
G. Panina, Novartis |
| H. Gringolts, Johnson & Johnson |
C. Rondinone, Roche |
| B. Hirshberg, AstraZeneca |
P. Stein, Johnson & Johnson |
| H.L. Katzeff, Merck |
A.D. Toft, Novo Nordisk |
| H. Khatami, Roche |
| |
|
|
|
WebStudio.co.il
